E

ECO Animal Health Group PLC
LSE:EAH

Watchlist Manager
ECO Animal Health Group PLC
LSE:EAH
Watchlist
Price: 110 GBX Market Closed
Market Cap: 74.5m GBX

ECO Animal Health Group PLC
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ECO Animal Health Group PLC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
ECO Animal Health Group PLC
LSE:EAH
Revenue
ÂŁ85.8m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
7%
GlaxoSmithKline PLC
LSE:GSK
Revenue
ÂŁ32.2B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
3%
AstraZeneca PLC
LSE:AZN
Revenue
$58.1B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
9%
Verona Pharma PLC
NASDAQ:VRNA
Revenue
$221.7m
CAGR 3-Years
77%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Revenue
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$3.2B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
8%
No Stocks Found

ECO Animal Health Group PLC
Glance View

Market Cap
74.5m GBX
Industry
Pharmaceuticals

ECO Animal Health Group Plc engages in the development, registration and marketing of pharmaceutical products for animals. The company is headquartered in New Malden, Surrey and currently employs 207 full-time employees. The firm's segments include UK, China and Japan, North America, South and South East Asia, Latin America, Europe and the Rest of the World. The firm's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. Its products include Aivlosin, Ecomectin and others. Aivlosin is a macrolide antibiotic for treatment of respiratory and enteric diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. Its Ecoheart, Ecotraz and Ecomintic are for the treatment and prevention of parasites in cattle, sheep, pigs, horses and dogs.

EAH Intrinsic Value
145.32 GBX
Undervaluation 24%
Intrinsic Value
Price
E

See Also

What is ECO Animal Health Group PLC's Revenue?
Revenue
85.8m GBP

Based on the financial report for Sep 30, 2025, ECO Animal Health Group PLC's Revenue amounts to 85.8m GBP.

What is ECO Animal Health Group PLC's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for ECO Animal Health Group PLC have been 3% over the past three years , and 7% over the past ten years .

Back to Top